5 sources checked · Left, Center, and Right included · 5m ago
Mostly Same
Company behind 2022 formula shortage to pay $384M over tainted formula
All headlines are identical, factually reporting the company's payment for the 2022 formula shortage.
1 Left3 Center1 Right
Same story. Mostly aligned wording.Outlets across the spectrum framed this event in roughly the same way today.
MOSTLY SAME
As of September 15, 2026 at 6:30 PM, this is how Optics News reads the wording differences in this story.
What happenedAbbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Michigan and Arizona plants.
The headline splitThe headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidenceMedium confidence. 5 sources across 3 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
5 sources across 3 bias buckets agree on the event.
Framing confidenceMostly same
0/99 — the outlets mostly agree on the headline takeaway.
WHAT EACH SIDE EMPHASIZED
Left / center-leftCompany behind 2022 formula shortage to pay $384M over tainted formula
The Plain Dealer Cleveland · Center-left · News report
CenterCompany behind 2022 formula shortage to pay $384M over tainted formula
The Star-Ledger (NJ.com) · Center · News report
Right / center-rightCompany behind 2022 formula shortage to pay $384M over tainted formula
Company behind 2022 formula shortage to pay $384M over tainted formula
Companyformula shortagepay $384Mtainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
Company behind 2022 formula shortage to pay $384M over tainted formula
Companyformula shortagepay $384Mtainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
Company behind 2022 formula shortage to pay $384M over tainted formula
Companyformula shortagepay $384Mtainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
Company behind 2022 formula shortage to pay $384M over tainted formula
Companyformula shortagepay $384Mtainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
